SOL short falls below 140 USDT, down 4.47% in 24H
According to market data, SOL briefly fell below 140 USDT and is now at 141.2 USDT, down 4.47% in 24H.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ASP Isotopes COO Robert Ainscow sells 25,000 shares for $97,625
BioCardia CEO Peter Altman buys 800 shares for $872
Inturai Ventures closes final tranche of private placement, raises $22,714.05
With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application
Adarx Pharmaceuticals Inc. has filed for an IPO in the United States to help fund the development of a pipeline of drugs aimed at treating various diseases by regulating gene expression.
